Inspirata Promotes Top Executives to Expanded Roles in Digital Pathology
20 sept. 2018 15h12 HE
|
Inspirata, Inc.
Tampa, FL, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that two of its executives have taken on expanded...
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
20 sept. 2018 07h37 HE
|
Precipio, Inc.
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
Inspirata to Demonstrate the Omnyx® Dynamyx™ Digital Pathology Software Suite at European Congress of Pathology 2018 in Bilbao, Spain September 9-11
06 sept. 2018 01h00 HE
|
Inspirata, Inc.
Bilbao, Spain, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata® Europe, Ltd. announced today that it will be an active participant at...
Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
18 juil. 2018 07h37 HE
|
Precipio, Inc.
Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today...
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
14 juin 2018 12h19 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
Potential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April Results
22 mai 2018 07h37 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 22, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced accelerating sales of its Pathology services in the month of...
Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%
14 mai 2018 07h37 HE
|
Precipio, Inc.
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Specialty...
Inspirata Announces ‘End-of-Support’ for Omnyx VL4 and VL120 Digital Pathology Whole Slide Image Scanners Effective May 4, 2019
11 mai 2018 06h00 HE
|
Inspirata, Inc.
Tampa, FL, May 11, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has provided 12-month notice officially...
Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology
03 avr. 2018 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 03, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that, in response to recent articles, its approach using ICE...
Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter
22 févr. 2018 08h39 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times...